Yigal Nochomovitz
Stock Analyst at Citigroup
(3.14)
# 1,144
Out of 5,147 analysts
316
Total ratings
45.63%
Success rate
0.89%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Maintains: Buy | $45 → $44 | $20.96 | +109.92% | 19 | Feb 25, 2026 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $16 → $17 | $13.45 | +26.39% | 8 | Feb 24, 2026 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $64 → $65 | $32.20 | +101.86% | 4 | Feb 19, 2026 | |
| KRYS Krystal Biotech | Maintains: Buy | $336 → $371 | $275.64 | +34.60% | 11 | Feb 18, 2026 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $203 → $204 | $132.25 | +54.25% | 3 | Feb 12, 2026 | |
| ARDX Ardelyx | Maintains: Buy | $11 → $14 | $6.55 | +113.74% | 17 | Jan 9, 2026 | |
| STTK Shattuck Labs | Maintains: Neutral | $2 → $4 | $3.92 | +2.04% | 5 | Jan 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Neutral | $9 → $7 | $8.23 | -14.95% | 9 | Jan 6, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $33 → $36 | $24.56 | +46.58% | 2 | Jan 6, 2026 | |
| ARVN Arvinas | Upgrades: Buy | $10 → $15 | $13.27 | +13.04% | 11 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $60 | $24.20 | +147.93% | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $7.76 | -9.79% | 1 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $270 | $198.31 | +36.15% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $24 | $5.25 | +357.14% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $77 | $60.14 | +28.03% | 22 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $31 | $22.97 | +34.96% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6 | $1.37 | +337.96% | 11 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $399 → $405 | $316.99 | +27.76% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $6.21 | +125.44% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $1.90 | +321.05% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $56 | $20.37 | +174.91% | 9 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $46 | $26.35 | +74.57% | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $16.59 | +141.11% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $19.22 | +259.00% | 9 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $23.29 | -5.54% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.2 → $1.9 | $1.47 | +29.25% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $51 | $21.71 | +134.91% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $13.49 | +285.47% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $16.76 | -58.23% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.24 | +301.79% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $34.74 | +58.32% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $17.56 | +87.93% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.99 | +603.52% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.63 | -26.38% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.59 | +25.79% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.46 | +46.52% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $2.57 | -61.09% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $5.42 | +545.76% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $23.39 | +468.62% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $3.88 | +312.37% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.48 | +575.68% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.72 | +599.71% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.70 | - | 14 | Sep 28, 2021 |
Apellis Pharmaceuticals
Feb 25, 2026
Maintains: Buy
Price Target: $45 → $44
Current: $20.96
Upside: +109.92%
ORIC Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $16 → $17
Current: $13.45
Upside: +26.39%
IDEAYA Biosciences
Feb 19, 2026
Maintains: Buy
Price Target: $64 → $65
Current: $32.20
Upside: +101.86%
Krystal Biotech
Feb 18, 2026
Maintains: Buy
Price Target: $336 → $371
Current: $275.64
Upside: +34.60%
Neurocrine Biosciences
Feb 12, 2026
Maintains: Buy
Price Target: $203 → $204
Current: $132.25
Upside: +54.25%
Ardelyx
Jan 9, 2026
Maintains: Buy
Price Target: $11 → $14
Current: $6.55
Upside: +113.74%
Shattuck Labs
Jan 6, 2026
Maintains: Neutral
Price Target: $2 → $4
Current: $3.92
Upside: +2.04%
Arcturus Therapeutics Holdings
Jan 6, 2026
Maintains: Neutral
Price Target: $9 → $7
Current: $8.23
Upside: -14.95%
ACADIA Pharmaceuticals
Jan 6, 2026
Maintains: Buy
Price Target: $33 → $36
Current: $24.56
Upside: +46.58%
Arvinas
Jan 6, 2026
Upgrades: Buy
Price Target: $10 → $15
Current: $13.27
Upside: +13.04%
Dec 12, 2025
Maintains: Buy
Price Target: $21 → $60
Current: $24.20
Upside: +147.93%
Dec 10, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $7.76
Upside: -9.79%
Dec 9, 2025
Initiates: Buy
Price Target: $270
Current: $198.31
Upside: +36.15%
Nov 14, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $5.25
Upside: +357.14%
Nov 12, 2025
Maintains: Buy
Price Target: $87 → $77
Current: $60.14
Upside: +28.03%
Nov 11, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $22.97
Upside: +34.96%
Nov 10, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $1.37
Upside: +337.96%
Nov 10, 2025
Maintains: Buy
Price Target: $399 → $405
Current: $316.99
Upside: +27.76%
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $6.21
Upside: +125.44%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $1.90
Upside: +321.05%
Oct 29, 2025
Maintains: Buy
Price Target: $54 → $56
Current: $20.37
Upside: +174.91%
Oct 28, 2025
Maintains: Buy
Price Target: $27 → $46
Current: $26.35
Upside: +74.57%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $16.59
Upside: +141.11%
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $19.22
Upside: +259.00%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $23.29
Upside: -5.54%
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.47
Upside: +29.25%
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $21.71
Upside: +134.91%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $13.49
Upside: +285.47%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $16.76
Upside: -58.23%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.24
Upside: +301.79%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $34.74
Upside: +58.32%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $17.56
Upside: +87.93%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.99
Upside: +603.52%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.63
Upside: -26.38%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.59
Upside: +25.79%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.46
Upside: +46.52%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $2.57
Upside: -61.09%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $5.42
Upside: +545.76%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $23.39
Upside: +468.62%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $3.88
Upside: +312.37%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.48
Upside: +575.68%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.72
Upside: +599.71%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.70
Upside: -